Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism

Infection and Immunity

Volumn 71, Issue 2, 2003, Pages 708-716

  Chen, Jeffrey M ^a   Alexander, David C ^a   Behr, Marcel A ^b   Liu, Jun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALANINE DEHYDROGENASE; BCG VACCINE; DEAMINASE; LIVE VACCINE; NITROGEN; SERINE;

AMINO ACID METABOLISM; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE EXPRESSION; LUNG TUBERCULOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ALANINE; ALANINE DEHYDROGENASE; AMINO ACID OXIDOREDUCTASES; ANIMALS; BCG VACCINE; CATTLE; CULTURE MEDIA; FRAMESHIFT MUTATION; GLUTAMATE-AMMONIA LIGASE; L-SERINE DEHYDRATASE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; SERINE;

EID: 0037306539     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.2.708-716.2003     Document Type: Article

References (35)

1. Alvarez, M. E., and C. M. McCarthy. 1984. Glutamine synthetase from Mycobacterium avium. Can. J. Microbiol. 30:353-359.
2. Andersen, A. B., P. Andersen, and L. Ljungqvist. 1992. Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect. Immun. 60:2317-2323.
3. Andersen, P. 2001. TB vaccines: progress and problems. Trends Immunol. 22:160-168.
4. Barclay, R., and P. R. Wheeler. 1989. Metabolism of mycobacterium in tissues, p. 37-106. In C. Ratledge, J. Stanford, and J. M. Grange (ed.), Clinical aspects of mycobacterial disease. Academic Press, London, United Kingdom.
5. Behr, M. A. 2002. BCG-different strains, different vaccines? Lancet Infect. Dis. 2:86-92.
6. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by wholegenome DNA microarray. Science 284:1520-1523.
7. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43: 717-731.
8. Brandt, L., J. F. Cunha, A. W. Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:672-678.
9. Brewer, T. F., and G. A. Colditz. 1995. Relationship between Bacille Calmette-Guerin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin. Infect. Dis. 20:126-135.
10. Chan, K., T. Knaak, L. Satkamp, O. Humbert, S. Falkow, and L. Ramakrishnan. 2002. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc. Natl. Acad. Sci. USA 99: 3920-3925.
11. Comstock, G. W. 1988. Identification of an effective vaccine against tuberculosis. Am. Rev. Respir. Dis. 138:479-480.
12. Dworski, M. 1973. Efficacy of bacillus Calmette-Guerin and isoniazid-resistant bacillus Calmette-Guerin with and without isoniazid chemoprophylaxis from day of vaccination. I. Experimental findings in guinea pigs. Am. Rev. Respir. Dis. 108:294-300.
13. Fine, P. E. M., I. A. M. Carneiro, J. B. Millstien, and C. J. Clements. 1999. Issues relating to the use of BCG in immunization programmes. A discussion document, p. 1-45. In WHO vaccines and biologicals. (Publication no. 99.23.) World Health Organization, Geneva, Switzerland.
14. Fine, P. E. M. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
15. Fine, P. E. M., and E. Vynnycky. 1998. The effect of heterologous immunity upon the apparent efficacy of (e.g., BCG) vaccines. Vaccine 16:1923-1928.
16. Fritz, C., S. Maass, A. Kreft, and F.-C. Bange. 2002. Dependence of Mycobacterium bovis BCG on anaerobic nitrate reductase for persistence is tissue specific. Infect. Immun. 70:286-291.
17. Harth, G., and M. A. Horwitz. 1999. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J. Exp. Med. 189:1425-1436.
18. Harth, G., D. L. Clemens, and M. A. Horwitz. 1994. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc. Natl. Acad. Sci. USA 91:9342-9346.
19. Harth, G., P. C. Zamecnik, J. Y. Tang, D. Tabatadze, and M. A. Horwitz. 2000. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc. Natl. Acad. Sci. USA 97:418-423.
20. Horwitz, M. A., G. Harth, B. J. Dillon, and S. Maslesa-Galic. 2000. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97:13853-13858.
21. Hutter, B., and T. Dick. 1998. Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis. FEMS Microbiol. Lett. 167: 7-11.
22. Hutter, B. F., and M. Singh. 1999. Properties of the 40 kDa antigen of Mycobacterium tuberculosis, a functional L-alanine dehydrogenase. Biochem. J. 343:669-672.
23. James, B. W., A. Williams, and P. D. Marsh. 2000. The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium. J. Appl. Microbiol. 88:669-677.
24. Lyon, R. H., W. H. Hall, and C. Costas-Martinez. 1970. Utilization of amino acids during growth of Mycobacterium tuberculosis in rotary cultures. Infect. Immun. 1:513-520.
25. McCarthy, C. M. 1987. Utilization of nitrate or nitrite as single nitrogen source by Mycobacterium avium. J. Clin. Microbiol. 25:263-267.
26. McKinney, J. D., Z. B. Honer, E. J. Munoz-Elias, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. J. Jacobs, and D. G. Russell. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738.
27. Oettinger, T., M. Jorgensen, A. Ladefoged, K. Haslov, and P. Andersen. 1999. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber. Lung Dis. 79:243-250.
28. Orme, I. M. 1988. Induction of nonspecific acquired resistance and delayedtype hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:3310-3312.
29. Reitzer, L. J. 1996. Ammonia assimilation and the biosynthesis of glutamine, glutamate, aspartate, asparagine, L-alanine, and D-alanine, p. 391-407. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.),Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
30. Reitzer, L. J. 1996. Sources of nitrogen and their utilization. p. 380-390. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press. Washington, D.C.
31. Rosenkrands, I., R. A. Slayden, J. Crawford, C. Aagaard, C. E. Barry III, and P. Andersen. 2002. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J. Bacteriol. 184:3485-3491.
32. Schuffenhauer, G., T. Schrader, and J. R. Andreesen. 1999. Morpholineinduced formation of L-alanine dehydrogenase activity in Mycobacterium strain HE5. Arch. Microbiol. 171:417-423.
33. Siranosian, K. J., K. Ireton, and A. D. Grossman. 1993. Alanine dehydrogenase (ald) is required for normal sporulation in Bacillus subtilis. J. Bacteriol. 175:6789-6796.
34. Usha, V., R. Jayaraman, J. C. Toro, S. E. Hoffner, and K. S. Das. 2002. Glycine and alanine dehydrogenase activities are catalyzed by the same protein in Mycobacterium smegmatis: upregulation of both activities under microaerophilic adaptation. Can. J. Microbiol. 48:7-13.
35. Ward, M. J., H. Lew, and D. R. Zusman. 2000. Disruption of aldA influences the developmental process in Myxococcus xanthus. J. Bacteriol. 182:546-550.